Protocolo diagnóstico y terapéutico de la hipercalcemia en el paciente oncológico

Abstract

Hypercalcemia is a common and serious complication in patients with cancer, especially in cancers with bone metastases. Symptoms range from mild to severe, such as confusion and muscle weakness. The diagnosis is based on the measurement of calcium levels and differentiation from other causes. Treatment includes hydration, bisphosphonates, or denosumab and, in severe cases, hemodialysis. It is essential to treat the underlying malignancy in order to provide long-term control of hypercalcemia and to improve the patient's quality of life.